Skip to main content
Top

26-04-2024 | Hepatocellular Carcinoma | RESEARCH

Integrated Single Cell Analysis Reveals An Atlas of Tumor Associated Macrophages in Hepatocellular Carcinoma

Authors: Xinqiang Li, Ruixia Li, Xiaolong Miao, Xin Zhou, Bin Wu, Junning Cao, Chengyu Wang, Shipeng Li, Jinzhen Cai

Published in: Inflammation

Login to get access

Abstract

Hepatocellular carcinoma (HCC), one of the most prevalent cancers globally, is closely associated with tumor-associated macrophages (TAMs), including monocyte-derived macrophages and liver-resident Kupffer cells. Understanding TAM heterogeneity at the cellular level is crucial for developing effective HCC prevention and treatment strategies. In this study, we conducted an integrated single-cell analysis of four cohorts (GSE140228, GSE125449, GSE149614 and GSE156625) to elucidate the TAM landscape in HCC. We identified 284 gene markers, termed Panmyeloid markers, that characterize myeloid cells within this context. Our analysis distinguished six clusters of monocyte-derived macrophages (Macro1-Macro6) and four clusters of Kupffer cells (Kupffer1-Kupffer4). Notably, CXCL10 + macrophages and MT1G + Kupffer cells, predominantly located within tumor tissues, exhibited distinct functional characteristics relevant to HCC. We also explored cellular communication between TAMs and T cells, uncovering potential signaling pathways such as the CXCL10/CXCL11-CXCR3 and CXCL12-CXCR4 networks. These findings enhance our understanding of TAMs in HCC and open new avenues for targeted therapeutic interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chidambaranathan-Reghupaty, S., P.B. Fisher, and D. Sarkar. 2021. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in Cancer Research 149: 1–61.PubMedCrossRef Chidambaranathan-Reghupaty, S., P.B. Fisher, and D. Sarkar. 2021. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in Cancer Research 149: 1–61.PubMedCrossRef
3.
go back to reference Dou, L., et al. 2019. Macrophage Phenotype and Function in Liver Disorder. Frontiers in Immunology 10: 3112.PubMedCrossRef Dou, L., et al. 2019. Macrophage Phenotype and Function in Liver Disorder. Frontiers in Immunology 10: 3112.PubMedCrossRef
4.
go back to reference Wen, Y., et al. 2021. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cellular & Molecular Immunology 18 (1): 45–56.CrossRef Wen, Y., et al. 2021. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cellular & Molecular Immunology 18 (1): 45–56.CrossRef
5.
go back to reference Cheng, K., et al. 2022. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Communications (Lond) 42 (11): 1112–1140.CrossRef Cheng, K., et al. 2022. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Communications (Lond) 42 (11): 1112–1140.CrossRef
6.
go back to reference Mo, Z., et al. 2022. Single-cell transcriptomics reveals the role of Macrophage-Naive CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma. Journal of Translational Medicine 20 (1): 466.PubMedPubMedCentralCrossRef Mo, Z., et al. 2022. Single-cell transcriptomics reveals the role of Macrophage-Naive CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma. Journal of Translational Medicine 20 (1): 466.PubMedPubMedCentralCrossRef
7.
go back to reference Sun, Y., et al. 2021. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184 (2): 404–442.PubMedCrossRef Sun, Y., et al. 2021. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184 (2): 404–442.PubMedCrossRef
8.
go back to reference Sharma, A., et al. 2020. Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma. Cell 183 (2): 377–394.PubMedCrossRef Sharma, A., et al. 2020. Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma. Cell 183 (2): 377–394.PubMedCrossRef
9.
go back to reference MacParland, S.A., et al. 2018. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nature Communications 9 (1): 4383.PubMedPubMedCentralCrossRef MacParland, S.A., et al. 2018. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nature Communications 9 (1): 4383.PubMedPubMedCentralCrossRef
10.
go back to reference Zhang, Q., et al. 2019. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell 179 (4): 829–845.PubMedCrossRef Zhang, Q., et al. 2019. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell 179 (4): 829–845.PubMedCrossRef
11.
go back to reference Zheng, C., et al. 2017. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 169 (7): 1342–1356.PubMedCrossRef Zheng, C., et al. 2017. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 169 (7): 1342–1356.PubMedCrossRef
14.
go back to reference Qiu, Y., et al. 2021. Next frontier in tumor immunotherapy: Macrophage-mediated immune evasion. Biomark Research 9 (1): 72.CrossRef Qiu, Y., et al. 2021. Next frontier in tumor immunotherapy: Macrophage-mediated immune evasion. Biomark Research 9 (1): 72.CrossRef
15.
go back to reference Lu, C., et al. 2019. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities. Molecular Cancer 18 (1): 130.PubMedPubMedCentralCrossRef Lu, C., et al. 2019. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: Challenges and opportunities. Molecular Cancer 18 (1): 130.PubMedPubMedCentralCrossRef
16.
go back to reference Rafalik, M., et al. 2019. The identification of discontinuous epitope in the human cystatin C - Monoclonal antibody HCC3 complex. Journal of Proteomics 191: 58–67.PubMedCrossRef Rafalik, M., et al. 2019. The identification of discontinuous epitope in the human cystatin C - Monoclonal antibody HCC3 complex. Journal of Proteomics 191: 58–67.PubMedCrossRef
17.
go back to reference Yang, F., et al. 2020. Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma. Cancer Research 80 (18): 3892–3905.PubMedCrossRef Yang, F., et al. 2020. Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma. Cancer Research 80 (18): 3892–3905.PubMedCrossRef
18.
go back to reference De Ponti, A., et al. 2015. A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma. Cancer Letters 369 (2): 396–404.PubMedCrossRef De Ponti, A., et al. 2015. A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma. Cancer Letters 369 (2): 396–404.PubMedCrossRef
19.
go back to reference Fan, J., et al. 2021. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma. Molecular Immunology 136: 82–97.PubMedCrossRef Fan, J., et al. 2021. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma. Molecular Immunology 136: 82–97.PubMedCrossRef
21.
go back to reference Sica, A., P. Invernizzi, and A. Mantovani. 2014. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology 59 (5): 2034–2042.PubMedCrossRef Sica, A., P. Invernizzi, and A. Mantovani. 2014. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology 59 (5): 2034–2042.PubMedCrossRef
22.
go back to reference Liang, Y., et al. 2019. Thymic stromal lymphopoietin epigenetically upregulates Fc receptor gamma subunit-related receptors on antigen-presenting cells and induces T(H)2/T(H)17 polarization through dectin-2. The Journal of Allergy and Clinical Immunology 144 (4): 1025–1035.PubMedCrossRef Liang, Y., et al. 2019. Thymic stromal lymphopoietin epigenetically upregulates Fc receptor gamma subunit-related receptors on antigen-presenting cells and induces T(H)2/T(H)17 polarization through dectin-2. The Journal of Allergy and Clinical Immunology 144 (4): 1025–1035.PubMedCrossRef
23.
go back to reference Liu, H., et al. 2013. Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. International Journal of Biochemistry & Cell Biology 45 (2): 408–418.CrossRef Liu, H., et al. 2013. Characterization of fibrinogen-like protein 2 (FGL2): Monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. International Journal of Biochemistry & Cell Biology 45 (2): 408–418.CrossRef
24.
go back to reference Bchir, S., et al. 2021. Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: Correlations with oxidative and inflammatory markers. Clinical and Experimental Medicine 21 (3): 457–465.PubMedCrossRef Bchir, S., et al. 2021. Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: Correlations with oxidative and inflammatory markers. Clinical and Experimental Medicine 21 (3): 457–465.PubMedCrossRef
25.
go back to reference Chen, J., J.A. Gingold, and X. Su. 2019. Immunomodulatory TGF-beta Signaling in Hepatocellular Carcinoma. Trends in Molecular Medicine 25 (11): 1010–1023.PubMedCrossRef Chen, J., J.A. Gingold, and X. Su. 2019. Immunomodulatory TGF-beta Signaling in Hepatocellular Carcinoma. Trends in Molecular Medicine 25 (11): 1010–1023.PubMedCrossRef
26.
go back to reference Morse, M.A., et al. 2019. The Role of Angiogenesis in Hepatocellular Carcinoma. Clinical Cancer Research 25 (3): 912–920.PubMedCrossRef Morse, M.A., et al. 2019. The Role of Angiogenesis in Hepatocellular Carcinoma. Clinical Cancer Research 25 (3): 912–920.PubMedCrossRef
27.
go back to reference Kumar, A.R., et al. 2021. Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment. Current Drug Targets 22 (11): 1288–1316.PubMedCrossRef Kumar, A.R., et al. 2021. Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment. Current Drug Targets 22 (11): 1288–1316.PubMedCrossRef
28.
go back to reference Xiao, Z., Y. Wang, and H. Ding. 2019. XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC. Cell & Bioscience 9: 6.CrossRef Xiao, Z., Y. Wang, and H. Ding. 2019. XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC. Cell & Bioscience 9: 6.CrossRef
29.
go back to reference Liu, Y., et al. 2019. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC. Clinical Cancer Research 25 (13): 4141–4154.PubMedCrossRef Liu, Y., et al. 2019. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC. Clinical Cancer Research 25 (13): 4141–4154.PubMedCrossRef
30.
go back to reference Li, J., et al. 2020. The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression. Cell Death & Disease 11 (11): 961.CrossRef Li, J., et al. 2020. The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression. Cell Death & Disease 11 (11): 961.CrossRef
31.
go back to reference Wang, D., et al. 2019. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression. Gut 68 (10): 1846–1857.PubMedCrossRef Wang, D., et al. 2019. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression. Gut 68 (10): 1846–1857.PubMedCrossRef
32.
go back to reference Peng, Z.P., et al. 2020. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. Journal of Hepatology 73 (4): 906–917.PubMedCrossRef Peng, Z.P., et al. 2020. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. Journal of Hepatology 73 (4): 906–917.PubMedCrossRef
33.
go back to reference Tian, X., et al. 2019. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. Journal of Hematology & Oncology 12 (1): 84.CrossRef Tian, X., et al. 2019. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. Journal of Hematology & Oncology 12 (1): 84.CrossRef
34.
35.
go back to reference House, I.G., et al. 2020. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clinical Cancer Research 26 (2): 487–504.PubMedCrossRef House, I.G., et al. 2020. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clinical Cancer Research 26 (2): 487–504.PubMedCrossRef
36.
go back to reference Rahma, O.E., and F.S. Hodi. 2019. The Intersection between Tumor Angiogenesis and Immune Suppression. Clinical Cancer Research 25 (18): 5449–5457.PubMedCrossRef Rahma, O.E., and F.S. Hodi. 2019. The Intersection between Tumor Angiogenesis and Immune Suppression. Clinical Cancer Research 25 (18): 5449–5457.PubMedCrossRef
37.
go back to reference Nemeth, J., et al. 2009. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50 (4): 1251–1262.PubMedCrossRef Nemeth, J., et al. 2009. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50 (4): 1251–1262.PubMedCrossRef
38.
go back to reference Wilson, C.L., et al. 2015. NFkappaB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nature Communications 6: 6818.PubMedCrossRef Wilson, C.L., et al. 2015. NFkappaB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nature Communications 6: 6818.PubMedCrossRef
39.
go back to reference Cheng, W.L., et al. 2021. The Role of EREG/EGFR Pathway in Tumor Progression. International Journal of Molecular Sciences 22(23). Cheng, W.L., et al. 2021. The Role of EREG/EGFR Pathway in Tumor Progression. International Journal of Molecular Sciences 22(23).
40.
go back to reference Tacke, F. 2017. Targeting hepatic macrophages to treat liver diseases. Journal of Hepatology 66 (6): 1300–1312.PubMedCrossRef Tacke, F. 2017. Targeting hepatic macrophages to treat liver diseases. Journal of Hepatology 66 (6): 1300–1312.PubMedCrossRef
41.
go back to reference Blauw, L.L., et al. 2020. A Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis? Trends in Endocrinology and Metabolism 31 (5): 334–343.PubMedCrossRef Blauw, L.L., et al. 2020. A Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis? Trends in Endocrinology and Metabolism 31 (5): 334–343.PubMedCrossRef
42.
go back to reference Wang, Y., et al. 2015. Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells. Hepatology 62 (6): 1710–1722.PubMedCrossRef Wang, Y., et al. 2015. Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells. Hepatology 62 (6): 1710–1722.PubMedCrossRef
44.
go back to reference Li, C., et al. 2014. AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer. Oncology Research 22 (4): 203–211.PubMedCrossRef Li, C., et al. 2014. AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer. Oncology Research 22 (4): 203–211.PubMedCrossRef
45.
go back to reference Li, C., et al. 2016. High-Content Functional Screening of AEG-1 and AKR1C2 for the Promotion of Metastasis in Liver Cancer. Journal of Biomolecular Screening 21 (1): 101–107.PubMedCrossRef Li, C., et al. 2016. High-Content Functional Screening of AEG-1 and AKR1C2 for the Promotion of Metastasis in Liver Cancer. Journal of Biomolecular Screening 21 (1): 101–107.PubMedCrossRef
46.
go back to reference Yang, J., et al. 2019. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression. Theranostics 9 (20): 5810–5827.PubMedPubMedCentralCrossRef Yang, J., et al. 2019. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression. Theranostics 9 (20): 5810–5827.PubMedPubMedCentralCrossRef
47.
go back to reference Hughes, C.E., and R.J.B. Nibbs. 2018. A guide to chemokines and their receptors. FEBS Journal 285 (16): 2944–2971.PubMedCrossRef Hughes, C.E., and R.J.B. Nibbs. 2018. A guide to chemokines and their receptors. FEBS Journal 285 (16): 2944–2971.PubMedCrossRef
48.
go back to reference Schuster, S., et al. 2015. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Biochemical and Biophysical Research Communications 458 (2): 334–340.PubMedCrossRef Schuster, S., et al. 2015. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Biochemical and Biophysical Research Communications 458 (2): 334–340.PubMedCrossRef
49.
50.
go back to reference Wu, X.L., et al. 2020. Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway. Journal of Zhejiang University. Science. B 21 (3): 234–245.PubMedPubMedCentralCrossRef Wu, X.L., et al. 2020. Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway. Journal of Zhejiang University. Science. B 21 (3): 234–245.PubMedPubMedCentralCrossRef
52.
go back to reference Tan, J., et al. 2023. TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. Journal of Hepatology 79 (1): 126–140.PubMedCrossRef Tan, J., et al. 2023. TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. Journal of Hepatology 79 (1): 126–140.PubMedCrossRef
53.
go back to reference Cheng, S., et al. 2021. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184 (3): 792–809.PubMedCrossRef Cheng, S., et al. 2021. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184 (3): 792–809.PubMedCrossRef
54.
go back to reference Wei, J., et al. 2021. Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data. Frontiers in Cell and Development Biology 9: 749210.CrossRef Wei, J., et al. 2021. Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data. Frontiers in Cell and Development Biology 9: 749210.CrossRef
55.
go back to reference He, H., et al. 2023. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discovery 9 (1): 60.PubMedPubMedCentralCrossRef He, H., et al. 2023. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discovery 9 (1): 60.PubMedPubMedCentralCrossRef
56.
go back to reference Liu, Y., et al. 2023. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. Journal of Hepatology 78 (4): 770–782.PubMedCrossRef Liu, Y., et al. 2023. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. Journal of Hepatology 78 (4): 770–782.PubMedCrossRef
57.
go back to reference Wei, Y., et al. 2019. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. Gastroenterology 156 (6): 1890–1904.PubMedCrossRef Wei, Y., et al. 2019. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. Gastroenterology 156 (6): 1890–1904.PubMedCrossRef
58.
go back to reference Liu, R.X., et al. 2015. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma. Hepatology 62 (6): 1779–1790.PubMedCrossRef Liu, R.X., et al. 2015. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma. Hepatology 62 (6): 1779–1790.PubMedCrossRef
59.
go back to reference Chen, S., et al. 2021. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway. International Journal of Oncology 59(2). Chen, S., et al. 2021. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway. International Journal of Oncology 59(2).
60.
go back to reference Lu, Y., et al. 2022. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nature Communications 13 (1): 4594.PubMedPubMedCentralCrossRef Lu, Y., et al. 2022. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nature Communications 13 (1): 4594.PubMedPubMedCentralCrossRef
61.
go back to reference Wu, T., et al. 2021. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2 (3):100141.PubMed Wu, T., et al. 2021. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2 (3):100141.PubMed
62.
go back to reference Venteicher, A.S., et al. 2017. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355(6332). Venteicher, A.S., et al. 2017. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355(6332).
64.
go back to reference Li, S., et al. 2021. Autophagic activation of IRF-1 aggravates hepatic ischemia-reperfusion injury via JNK signaling. MedComm 2020 2 (1): 91–100.PubMedPubMedCentral Li, S., et al. 2021. Autophagic activation of IRF-1 aggravates hepatic ischemia-reperfusion injury via JNK signaling. MedComm 2020 2 (1): 91–100.PubMedPubMedCentral
65.
go back to reference Li, S.P., et al. 2022. Multiplex Immunofluorescence for Detection of Spatial Distributions of Infiltrating T Cells Within Different Regions of Hepatic Lobules During Liver Transplantation Rejection. Inflammation 45 (2): 651–664.PubMedCrossRef Li, S.P., et al. 2022. Multiplex Immunofluorescence for Detection of Spatial Distributions of Infiltrating T Cells Within Different Regions of Hepatic Lobules During Liver Transplantation Rejection. Inflammation 45 (2): 651–664.PubMedCrossRef
Metadata
Title
Integrated Single Cell Analysis Reveals An Atlas of Tumor Associated Macrophages in Hepatocellular Carcinoma
Authors
Xinqiang Li
Ruixia Li
Xiaolong Miao
Xin Zhou
Bin Wu
Junning Cao
Chengyu Wang
Shipeng Li
Jinzhen Cai
Publication date
26-04-2024
Publisher
Springer US
Published in
Inflammation
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-024-02026-1
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.